Dr. Nicole Paland

Berufserfahrung von Nicole Paland

• Bis heute 1 Jahr und 8 Monate, seit Sep. 2022

  Head of Product Development

  Minerva Biolabs GmbH

• Bis heute 3 Jahre und 2 Monate, seit März 2021

  Project Leader Product Development

  Minerva Biolabs GmbH

• Bis heute 5 Jahre und 9 Monate, seit Aug. 2018

  Scientific Writer

  EasyBioWri

• 7 Monate, Juli 2020 - Jan. 2021

  Medical Writer

  Medical Cannabis Research Center Rambam Health Care Center

• 1 Jahr und 9 Monate, Sep. 2016 - Mai 2018

  Senior Researcher

  University of Haifa, Prof. Sarit Larisch

  Role of mutual regulation between ARTS and p53 in promoting apoptosis and cancer prevention - Planning and implementing projects - Supervision of students

• 1 Jahr und 10 Monate, Nov. 2014 - Aug. 2016

  Senior Researcher

  Technion, Prof. Simone Engelender

  Investigated the role of Gaucher's Disease as a risk factor for the development of idiopathic Parkinson's Disease • Established the method of CRISPR and Real Time PCR in the lab

• 3 Jahre, Sep. 2011 - Aug. 2014

  Senior Postdoc

  Technion, Lipid Research Group Prof. Michael Aviram/Prof. Bianca Fuhrman

  Investigated the function of the urokinase-type plasminogen activator (uPA)/urokinase receptor (uPAR) system for the development and progression of atherosclerosis, non-alcoholic fatty liver disease and diabetes using uPAR knock-out mice and in vitro cell culture approaches.

• 2 Jahre, Sep. 2009 - Aug. 2011

  Postdoctoral Fellow

  Technion, Prof. Tamar Kleinberger

  Elucidation of the mechanism of function of the adenoviral protein E4orf4. One project investigates the function of E4orf4 for the life cycle of the virus using ChIP and real time PCR to determine gene expression of certain viral genes. A second project deals with the influence of E4orf4 on the microenvironment of the cell in which it is expressed and the effect on the neighbouring cancer cells in comparison to their corresponding normal cells .

• 2 Jahre und 6 Monate, Jan. 2007 - Juni 2009

  Postdoctoral Fellow

  Weizmann Institute of Science, Rehovot, Israel

  Investigation of the influence of the microenvironment on cancer cells using an in vitro model of prostate cancer http://mcr.aacrjournals.org/content/7/8/1212.abstract http://www.primaproject.org/doc/journals/Kogan-Sakin_Carcinogenesis_2009.pdf

• 1 Jahr und 4 Monate, Sep. 2005 - Dez. 2006

  Postdoctoral Fellow

  Max Planck Institute for Infection Biology

  Investigation of the importance of the down-regulation of tumor necrosis factor receptor 1 (TNFR1) on the surface of infected cells. (Paland, N., Boehme, L., Gurumurthy, Kumar, R., Mäurer, A., Rudel, T., Reduced display of tumor necrosis factor receptor I at the host cell surface supports infection with Chlamydia trachomatis. J Biol Chem. 2008 Mar 7;283(10):6438-48

• 3 Jahre und 11 Monate, Apr. 2001 - Feb. 2005

  PhD Student

  Max Planck Institute for Infection Biology

  Characterization of the anti-apoptotic factors of Chlamydia spp. http://www.ncbi.nlm.nih.gov/pubmed/18167350 http://www.ncbi.nlm.nih.gov/pubmed/17069460 http://www.ncbi.nlm.nih.gov/pubmed/16984419

• 11 Monate, Apr. 2000 - Feb. 2001

  Diploma Thesis Prof. Ropers/Prof. Wolfgang Berger

  Max Planck Institute for Molecular Genetics

  Characterization of the gene product of the RP2 (retinopathia pigmentosa) gene http://hmg.oxfordjournals.org/content/10/11/1177.abstract